Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study

Oda E. van den Berg, Kamelia R. Stanoeva, Rens Zonneveld, Denise Hoek-van Deursen, Fiona van der Klis, Jan van de Kassteele, Eelco Franz, Marieke Opsteegh, Ingrid H. M. Friesema, Laetitia M. Kortbeek

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9-1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.

Original languageEnglish
Article numbere136
JournalEpidemiology and Infection
Volume151
Early online date2023
DOIs
Publication statusPublished - 28 Jul 2023

Keywords

  • The Netherlands
  • Toxoplasma gondii
  • risk factors
  • serology
  • seroprevalence

Cite this